USP9YP35

Across TCGA pan-cancer cohorts, USP9YP35 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated USP9YP35 data layer.

The strongest signal is observed in sarcoma (SARC), where higher USP9YP35 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated USP9YP35 expression acts as an unfavorable survival marker.

SARC are the cancer types where USP9YP35 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Tertile	All	0.096	0.611	.005	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

USP9YP35–SARC (DFS)

Open the SARC breakdown →